View Older Stories View More Recent Stories

Aug 29, 2023 11:02AM AUNA APPOINTS ANASOFIA SANCHEZ JUAREZ TO ITS BOARD OF DIRECTORS
Aug 14, 2023 08:08PM Activists back off Salesforce after share price recovery
Aug 14, 2023 10:37AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2023 10:37AM Form 13F-NT Farallon Capital Europe For: Jun 30
Aug 14, 2023 10:36AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
Aug 11, 2023 05:18PM Form SC 13D CHINOOK THERAPEUTICS, Filed by: Farallon Capital Partners, L.P.
Aug 10, 2023 03:57PM Form SC 13G Forte Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
Aug 1, 2023 04:02PM Forte Biosciences (FBRX) Announces $25M Financing and R&D Update for FB-102
Aug 1, 2023 04:01PM Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
Jul 31, 2023 09:00AM Farallon Capital Management Closes Fourth Real Estate Fund with over $650 Million in Aggregate Investor Commitments
Jul 7, 2023 12:10PM Form D/A Farallon Capital F5 Inve
Jul 7, 2023 12:09PM Form D/A Farallon Capital F5 Inve
Jun 16, 2023 05:22PM Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
Jun 2, 2023 05:00PM Form SC 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 31, 2023 12:30PM Farallon Capital Management Comments on Election of All Three of Its Nominees to Exelixis’ Board
May 16, 2023 05:26PM Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
May 15, 2023 12:34PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 15, 2023 08:51AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 15, 2023 08:49AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
May 15, 2023 08:49AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
May 15, 2023 08:49AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
May 15, 2023 08:47AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 15, 2023 08:45AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 15, 2023 08:45AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
May 15, 2023 08:45AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
May 15, 2023 08:43AM Form 13F-NT Farallon Capital Europe For: Mar 31
May 11, 2023 12:28PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 8, 2023 01:22PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 8, 2023 11:59AM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 8, 2023 05:27AM Exelixis (EXEL) Announces Departure of Lance Willsey from Board
May 7, 2023 11:30PM Farallon Capital Management Comments on Successful Campaign for Change at Exelixis
May 7, 2023 05:00PM Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors
May 3, 2023 02:19PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 3, 2023 10:29AM Form DEFC14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 1, 2023 05:08PM Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
Apr 27, 2023 05:29PM Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
Apr 25, 2023 03:18PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 24, 2023 02:37PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 21, 2023 05:05PM Form PRRN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 13, 2023 04:11PM Exelixis (EXEL) Advances Board Refreshment Plan
Apr 13, 2023 04:11PM Exelixis Advances Board Refreshment Plan
Apr 13, 2023 12:00PM Nordstrom Rack to Open Five New California Stores in Davis, Elk Grove, Gilroy, Oceanside and San Mateo
Apr 11, 2023 04:06PM Theravance Biopharma (TBPH) Appoints Jim Kelly to its Board
Apr 11, 2023 04:05PM Theravance Biopharma, Inc. Announces Appointment of Jim Kelly, Managing Director at Weiss Asset Management, to Board of Directors
Apr 7, 2023 06:04AM Form SC 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 6, 2023 05:28PM Form PREC14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 6, 2023 04:59PM Form SC 13G Forest Road Acquisition Filed by: Farallon Capital Partners, L.P.
Apr 5, 2023 06:06PM Exelixis Reiterates Commitment to Shareholder Value Creation
Apr 5, 2023 12:39PM Form DFAN14A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Apr 5, 2023 08:04AM Farallon Issues Letter to Exelixis (EXEL) Board of Directors Outlining Case for Change
View More Recent Stories View Older Stories